Collagen shield delivery of tobramycin to the human eye

CLAO Journal

Volumn 24, Issue 3, 1998, Pages 166-168

  Taravella, Michael ^a,b   Stepp, Patricia ^a   Young, David ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DEXAMETHASONE; TOBRAMYCIN;

AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SAFETY; ENDOPHTHALMITIS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; CATARACT EXTRACTION; COLLAGEN; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TOBRAMYCIN;

EID: 0031880470     PISSN: 07338902     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Unterman SR, Rootman DS, Hill JM, et al: Collagen shield drug delivery: Therapeutic concentrations of tobramycin in the cornea and aqueous humor. JCRS 1988;14(5):500-504.
2. Chen CC, Takun H, Duzman E: Enhancement of the ocular bioavailability of topical tobramycin with the use of a collagen shield. JCRS 1993;19:242-245.
3. Phinney RB, Schwartz SD, Lee DA, et al: Collagen shield delivery of gentamicin and vancomycin. Archives Ophthal 106(11):1599-1604.
4. O'Brien TP, Sawusch MR, Dick JP: Use of collagen shields versus soft contact lenses to enhance penetration of topical tobramycin. JCRS 1988;14:505.
5. Aquavella JV, Ruffini JJ, LoCascio JA: Use of collagen shields as a surgical adjunct. JCRS 1988;14(5):492-495.
6. Marmer RH: Therapeutic and protective properties of the corneal collagen shield. JCRS 1988;14(5):496-499.
7. Poland DE, Kaufman HE: Clinical uses of collagen shields. JCRS 1988;14(5):489-491
8. Hasskjold E, Ohrstrom A, Usitalo RJ, et al: Use of collagen shields in cataract surgery. JCRS 1994;20(3):150-153
9. Renard G, Bennani N, Lutaj P, et al: Comparative study of a collagen corneal shield and subconjunctival injection at the end of cataract surgery. JCRS 1993;19:48-51.
10. National Committee Clinical Laboratory Standards: Minimum inhibitory concentration (MIC) interpretive standards for organisms other than Haemophilus spp., Neisseria gonorrhaeae, and Streptococci. NCCLS 1995;15(4).
11. Judge AJ, Katayoun N, Lee DA, et al: Corneal Endothelial Toxicity of Topical Anesthesia. Ophthalmology 1997;104(9):1373-1379.
12. Gills JP, Cherchio M, Raanan MG: Unpreserved lidocaine to control discomfort during cataract surgery using topical anesthesia. JCRS 1997;23:545-550.
13. Koch PS: Anterior chamber irrigation with unpreserved lidocaine 1% for anesthesia during cataract surgery. JCRS 1997;23:551-554.
14. Gardner S: Drug delivery from collagen shields. Ocular Therapeutics and Management. 1991;2(5):1-14.